Outcomes of Goniotomy With or Without Secondary Intraocular Lens Implantation in Pediatric Glaucoma Following Cataract Surgery: A Prospective Pilot Study

医学 四分位间距 眼压 青光眼 前瞻性队列研究 眼科 白内障手术 继发性青光眼 人工晶状体 外科
作者
Yu Zhang,Wan Chen,Tse‐Chun Lin,Xiulan Zhang,Dennis S.C. Lam,Weirong Chen
出处
期刊:Asia-Pacific journal of ophthalmology [Lippincott Williams & Wilkins]
卷期号:12 (5): 444-450 被引量:2
标识
DOI:10.1097/apo.0000000000000637
摘要

Purpose: To report the outcomes of a 120-degree goniotomy (GT) with or without secondary intraocular lens (IOL) implantation in glaucoma following cataract surgery (GFCS). Design: Prospective, observational study. Methods: Pediatric patients with GFCS who underwent standalone 120-degree GT or 120-degree GT combined with secondary IOL implantation (GT+IOL) from March 2022 to August 2022 at the Zhongshan Ophthalmic Center were recruited. Primary outcomes were intraocular pressure (IOP) and the number of ocular hypotensive medications. A secondary outcome was the surgical success rate. Success was defined as a postoperative IOP within the range of 5–21 mm Hg. Complete and qualified successes were defined, as the above, without and with ocular hypotensive medications, respectively. Results: Thirty-two eyes of 22 patients were included. The mean age at the time of GT was 68.5 ± 29.3 months. The mean follow-up duration was 12.2 ± 2.3 months (9–15 mo). Mean IOP decreased from 30.9 ± 4.8 mm Hg on 2 (interquartile range = 1) medications at baseline to 15.8 ± 3.6 mm Hg on 0 (interquartile range = 1.5) medication at the latest visit in all eyes. The overall complete and qualified success rates were 68.8% and 90.6%, respectively. There were no significant differences in IOP, number of medications, and complete and qualified success rates between the standalone GT and GT+IOL groups at the latest follow-up at 9 months postoperatively. Conclusions: To reduce the need for additional surgery, 120-degree GT was a safe and effective surgical treatment for GFCS in children, which could be combined with secondary IOL implantation in aphakic eyes with GFCS.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
研友_8RyzBZ发布了新的文献求助10
刚刚
没有昵称发布了新的文献求助10
1秒前
夏艳青发布了新的文献求助10
1秒前
1秒前
深情安青应助Melody采纳,获得10
3秒前
4秒前
寇博翔发布了新的文献求助10
4秒前
可爱的函函应助青藤之凉采纳,获得10
4秒前
852应助wings采纳,获得10
5秒前
迷路的麋鹿完成签到,获得积分10
5秒前
田様应助姣妹崽采纳,获得30
7秒前
Owen应助wq采纳,获得10
7秒前
天天快乐应助七月流火采纳,获得10
7秒前
橙子完成签到,获得积分10
9秒前
10秒前
10秒前
汉堡包应助heheha采纳,获得10
11秒前
阿丘完成签到,获得积分10
11秒前
zhang完成签到,获得积分10
11秒前
12秒前
YHHHH应助Youatpome采纳,获得20
13秒前
不学无术发布了新的文献求助10
13秒前
我会好好的完成签到,获得积分20
13秒前
SciGPT应助晓晓采纳,获得10
16秒前
踏雪无痕6509完成签到,获得积分10
16秒前
Owen应助x5kyi采纳,获得10
17秒前
善学以致用应助zero采纳,获得10
17秒前
Tian应助小李采纳,获得10
17秒前
17秒前
IVY完成签到 ,获得积分10
17秒前
yinyuli发布了新的文献求助10
18秒前
18秒前
ED应助踏雪无痕6509采纳,获得10
20秒前
打打应助研友_8RyzBZ采纳,获得10
22秒前
JianmaoChen发布了新的文献求助10
22秒前
木头人应助科研通管家采纳,获得10
23秒前
bkagyin应助科研通管家采纳,获得10
23秒前
24秒前
斯文败类应助科研通管家采纳,获得10
24秒前
科研通AI2S应助科研通管家采纳,获得10
24秒前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Cognitive Neuroscience: The Biology of the Mind (Sixth Edition) 1000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3959091
求助须知:如何正确求助?哪些是违规求助? 3505434
关于积分的说明 11123675
捐赠科研通 3237077
什么是DOI,文献DOI怎么找? 1788987
邀请新用户注册赠送积分活动 871477
科研通“疑难数据库(出版商)”最低求助积分说明 802821